Jefferies Boosts Price Target on Catalyst Health Solutions (CHSI) to $100 On Deal

Jefferies lifted its price target on Buy-rated Catalyst Health Solutions (NASDAQ: CHSI) from $68 to $100 after the deal to be acquired by SXC Health Solutions, saying holders should benefit from SXC's post-deal success.

The firm comments, "We are maintaining our Buy recommendation on CHSI despite yesterday's run given our view that the stock component of SXC's acquisition offer will enable CHSI shareholders to realize value from the strategic and financial benefits that the combined CHSI-SXCI entity will generate once the deal closes in 2H12. In line with our PT adjustment on SXCI, we are raising our CHSI PT to $100."

For an analyst ratings summary and ratings history on Catalyst Health Solutions click here. For more ratings news on Catalyst Health Solutions click here.

Shares of Catalyst Health Solutions closed at $85.23 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
• Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities